Revolution Medicines is seeking to solve the business and technical problem of developing novel targeted therapies for RAS-addicted cancers by providing biomarker operational expertise for phase three clinical trials.
Requirements
- Prior experience in clinical biomarker operation and/or sample management in phase three clinical trials is highly desirable.
- Should be proficient in Microsoft Excel, Microsoft PowerPoint applications.
- Experience in using Project Management tools is highly desired.
- Should be proficient in Microsoft Excel, Microsoft PowerPoint applications.
- Experience in using Project Management tools is desirable.
Responsibilities
- Operationalize the Program strategies to support early and late-stage development of portfolio assets.
- Guide Biospecimen Operations Lead on effectively managing early and late stage clinical trials.
- Train Biospecimen Operations Lead on Informed Consent Form development for all aspect of biospecimen collection.
- Effectively collaborate with biomarker scientists and clinical operations to ensure successful collection and CDx testing of clinical trial samples.
- Collaborate with diagnostic partners and internal cross-functional team members to ensure successful management of CDx samples.
- Work closely with Clinical operations group to meet clinical milestones.
- Work closely with biomarker scientist to oversee development of the scope of work, budgets, and timelines by CROs across all active studies.
Other
- Life sciences degree (MS or PhD) in scientific, medical, healthcare, or related discipline.
- 7+ years related professional experience in a clinical research setting, clinical/diagnostic laboratory.
- Should have experience of managing/mentoring team members.
- Excellent scientific and business communication skills, strong interpersonal/collaboration skills, and planning skills.
- Ability to think critically and creatively and be able to work independently to determine appropriate resources for resolution of problems.
